CLINICAL STUDIES ON PSEUDOPREGNANCY IN DOGS

Loading...
Thumbnail Image
Date
2018-08
Journal Title
Journal ISSN
Volume Title
Publisher
KARNATAKA VETERINARY, ANIMAL AND FISCHERIES SCIENCE UNIVERSITY, BIDAR
Abstract
A study on the prevalence, predisposing factors, clinical signs associated with pseudopregnancy and efficiency of dopamine agonists and management practices to reduce the clinical manifestation of pseudopregnancy was conducted. The prevalence of pseudopregnancy was 35.41% with highest prevalence in medium breeds and lowest in small breeds. The prevalence was higher in young (less than 2 years) and nulliparous female dogs. Age and parity showed a statistically significant influence on the exhibition of pseudopregnancy. The signs were exhibited during the anestrus stage of estrous cycle in majority of dogs as indicated by the serum progesterone values less than 1 ng/ml. The average number of days from last estrus was 63±2.25 days. The clinical signs varied widely between individuals and mammary development with milk or milk like secretion was the most common sign (96.08%). Physical changes and maternal instincts were also recorded and clinical signs were seen in less than 50% of the dogs. The complications like mastitis or mammary dermatitis were rare (3.96%). Cabergoline at 5µg/Kg BW once daily took an average of 6.4±0.65 days for complete recovery and bromocriptine at 10µg/Kg BW twice daily took an average of 9.5±0.73 days. Managemental practices like food and water withdrawal during night hours and application of Elizabethan collars for an average of 15±0.77 days also had a significant effect in reducing clinical signs compared to control group. Even though pseudopregnancy is a self-limiting condition, when clinical signs are exacerbated, compared to bromocriptine, cabergoline was found to be safe and effective. Managemental interventions were found to be effective in absence of veterinary aid.
Description
Keywords
Citation
Collections